RUNX1 and colorectal carcinoma: Further investigations revealed that CPX treatment resulted in upregulation of RUNX1 to bind to the promoter region of DJ-1 and subsequently inhibit its transcription, implying a transcriptional regulation of DJ-1 in CRC cells.